Group 1 - The company held the 12th meeting of the 4th Supervisory Board on July 8, 2025, with all three supervisors present, complying with the company's articles of association and relevant laws [1][2] - The Supervisory Board approved the proposal to use self-owned funds to pay part of the fundraising project expenses and to replace it with an equivalent amount of raised funds, which is expected to improve the efficiency of fund usage and align with the interests of the company and its shareholders [1][2] - The decision will not affect the normal progress of the fundraising investment projects and complies with relevant regulations, ensuring no harm to shareholder interests [1][2]

Core Viewpoint - The company, Shenzhen Xinyuren Technology Co., Ltd., is utilizing its own funds to pay for fundraising project expenses and will subsequently replace these with equivalent amounts from the raised funds, ensuring compliance with regulatory requirements and maintaining project efficiency [1][2][4]. Fundraising Overview - The company has successfully completed its initial public offering (IPO) of 24,438,597 shares at a price of RMB 23.68 per share, raising a total of approximately RMB 578.71 million. After deducting issuance costs of about RMB 72.51 million, the net proceeds amount to approximately RMB 506.20 million [1][2]. - The total investment for the fundraising projects is RMB 618.52 million, with RMB 462.25 million allocated from the raised funds [1]. Fund Utilization and Replacement Process - The company has opted to use its own funds for certain project expenses, particularly for land purchases, due to tax payment requirements that necessitate using a specific account not linked to the fundraising account. This approach allows for timely payments while ensuring that the raised funds are eventually used to reimburse these expenses [1][2]. - The process involves the company’s relevant departments preparing detailed payment records, followed by internal approvals, and then transferring equivalent amounts from the fundraising account to the company’s general account [2][4]. Impact on Company Operations - The decision to use self-funds for project expenses and later replace them with raised funds is expected to enhance the efficiency of fund utilization and project implementation, ensuring that the projects proceed smoothly without altering the intended use of the raised funds [4][5]. Approval and Oversight - The board of directors approved the use of self-funds for project expenses with a unanimous vote, and the supervisory board expressed agreement, confirming that this action does not affect the normal operation of the fundraising projects or violate any regulatory requirements [5][6]. - The sponsoring institution, Minsheng Securities, has conducted a review and found that the company has adhered to necessary procedures and regulations regarding the use of funds [6].

证券代码：603079 证券简称：圣达生物 公告编号：2025-031 浙江圣达生物药业股份有限公司 关于使用募集资金置换预先投入募投项目 及已支付发行费用的自筹资金的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 浙江圣达生物药业股份有限公司（以下简称"公司"、"圣达生物"） 拟使用募集资金置换预先已投入募集资金投资项目的自筹资金的金额为人民币 间距离募集资金到账时间不超过6个月，符合相关法规的要求。 一、募集资金基本情况 经中国证券监督管理委员会《关于同意浙江圣达生物药业股份有限公司向 特定对象发行股票注册的批复》（证监许可2025165号）文件核准，浙江圣达 生物药业股份有限公司向特定对象发行人民币普通股（A股）股票17,840,666 股，每股发行价格为人民币15.00元，募集资金总额为人民币267,609,990.00 元，扣除发行费用（不含税）人民币6,186,644.91元后，募集资金净额为人民 币261,423,345.09元。 上述募集资金到位情况业经天健会计师事务所（特殊普通合伙） ...

Group 1 - The company, Sichuan Hongda Co., Ltd., has raised a total of RMB 2,834,758,430.19 through the issuance of 609,600,000 shares at a price of RMB 4.68 per share, as approved by the China Securities Regulatory Commission [1] - The raised funds will be used to repay debts amounting to RMB 134,751.11 million and to supplement working capital with RMB 150,541.69 million [2] - The company has pre-invested RMB 96,541.50 million of its own funds to address debt issues before the raised funds were available, which it plans to replace with the raised funds [2][3] Group 2 - The total issuance costs amount to RMB 1,816.96 million, of which RMB 52.36 million has been paid using self-raised funds, and this amount will also be replaced with the raised funds [2] - The board of directors and the supervisory board have approved the use of raised funds to replace pre-invested self-raised funds, confirming compliance with relevant regulations [4] - The sponsor, CITIC Securities, has verified that the company’s actions comply with legal requirements and do not harm shareholder interests [4]

Core Viewpoint - Tianyu Biological Technology Co., Ltd. has announced the use of its own funds to pay for part of the fundraising investment project and will replace it with an equivalent amount of raised funds, ensuring the smooth implementation of the project without affecting the interests of shareholders [1][8][11]. Fundraising Basic Situation - The company raised a total of RMB 402.27 million by issuing 48.35 million shares at a price of RMB 8.32 per share, with a net amount of RMB 393.87 million after deducting issuance costs [1]. Fundraising Investment Project Situation - The company adjusted its fundraising usage plan due to the net amount being less than initially planned, with the project "Tianchang Longgang Red Cultural Tourism Scenic Area Engineering General Contracting Project" extended to be operational by December 2025 [3]. Reasons and Process for Using Own Funds - The company faced difficulties in directly using raised funds for certain payments, such as wages for migrant workers, which necessitated the use of its own funds initially, followed by a replacement with raised funds [5][6]. Impact on the Company - The decision to use self-funds for part of the project payments will not affect the normal implementation of the fundraising project and will not change the direction of the raised funds or harm the interests of shareholders [8][10]. Review Procedures and Opinions - The board of directors and the supervisory board have approved the use of self-funds and the subsequent replacement with raised funds, confirming that the decision aligns with the interests of the company and shareholders [9][10].

Summary of Key Points Core Viewpoint - The company intends to use raised funds to replace pre-invested self-raised funds for investment projects and expenses related to the issuance of shares, following necessary legal procedures and approvals [7][8]. Group 1: Fundraising Overview - The company has been approved to issue 45,312,900 shares at a price of RMB 11.50 per share, raising a total of RMB 521.0984 million, with a net amount of RMB 460.6722 million after deducting issuance costs [1][2]. - The total issuance costs amounted to RMB 60.4262 million (excluding VAT), with the net funds available for investment being lower than initially disclosed in the prospectus [2][3]. Group 2: Investment Project Adjustments - The total investment for the projects was adjusted from RMB 748.3020 million to RMB 612.3020 million, with the actual amount to be invested from the raised funds being RMB 460.6722 million [3][4]. - The company has made adjustments to the investment amounts for specific projects to ensure efficient use of the raised funds [2][3]. Group 3: Pre-Investment and Issuance Costs - The company has pre-invested a total of RMB 17.57628 million in the investment projects and has incurred issuance costs of RMB 12.9532 million, which will be replaced by the raised funds [5][6]. - The issuance costs include RMB 31.9541 million for underwriting and advisory fees, which have already been deducted from the total raised funds [6]. Group 4: Approval and Compliance - The board of directors and the supervisory board have approved the use of raised funds for replacing pre-invested amounts, and the process complies with relevant regulations [7][8]. - The accounting firm has issued a report confirming that the company's actions align with regulatory requirements and accurately reflect the situation regarding the use of funds [7].

Meeting Overview - The third meeting of the third Supervisory Board of the company was held with all three supervisors present, complying with relevant regulations and company rules [1]. Financial Management Proposals - The Supervisory Board approved the proposal to use part of the temporarily idle self-owned funds for entrusted financial management, with a limit of up to RMB 2,000 million, which is expected to enhance the efficiency of fund usage and generate investment returns [1][2]. - The proposal to use part of the temporarily idle over-raised funds for cash management was also approved, with a limit of up to RMB 94.2 million, ensuring compliance with regulatory requirements and not affecting the normal implementation of fundraising projects [2][3]. - The board approved the use of self-owned funds to pay for the required funds of fundraising projects, with an equivalent replacement of the raised funds, which is expected to improve the efficiency of fund usage without altering the intended use of the raised funds [3][4].

Core Points - The company has approved the use of raised funds to replace self-raised funds for investment projects and issuance expenses, totaling RMB 404,241,607.84 [1][5][6] Fundraising Overview - The company received approval from the China Securities Regulatory Commission to issue 70,989,958 shares at a price of RMB 24.00 per share, raising a total of RMB 1,703,758,992.00 [1][4] - After deducting issuance expenses, the net amount deposited into the company's special account was RMB 1,683,758,992.00 [4] Investment Project Details - The total investment for the "Annual Production of 60,000 Tons of Energy-Level Titanium (Alloy) Materials Full Industry Chain Project" is RMB 720,000,000.00, with planned raised fund input of RMB 170,375,900.00 [2][3] - The company has pre-invested RMB 403,061,428.63 from self-raised funds into the investment project before the raised funds were available [3][5] Issuance Expense Details - The total issuance expenses (excluding VAT) amounted to RMB 20,048,103.74, with RMB 20,000,000.00 remaining after deducting underwriting and sponsorship fees [4][5] - The company has also pre-paid issuance expenses using self-raised funds, which will be replaced by the raised funds [5] Approval and Compliance - The board and supervisory committee have approved the use of raised funds to replace pre-invested self-raised funds, confirming compliance with relevant laws and regulations [5][6] - The replacement of funds is within six months of the raised funds being received, ensuring no change in the intended use of the funds [5][6]

Group 1 - The company has successfully completed its initial public offering (IPO) by issuing 66.07 million shares at a price of 12.30 RMB per share, raising a total of 812.66 million RMB [1] - The funds raised will be used for specific projects, including a high-performance neodymium-iron-boron production project with a total investment of 944.15 million RMB, of which 818.10 million RMB is planned to be funded by the raised capital [2][3] - The company has pre-invested a total of 185.90 million RMB from its own funds into the projects before the IPO funds were available [3][4] Group 2 - The company has established a special account for the management of the raised funds and signed a tripartite supervision agreement with the sponsor and the bank [2] - The company has adjusted the amount of raised funds allocated to projects due to the actual net amount being lower than initially planned, ensuring that the projects will still be implemented without changing the intended use of funds [2][3] - The total issuance costs amounted to 82.32 million RMB, with 10.20 million RMB paid from self-raised funds, while the remaining costs were deducted from the raised funds [4][6] Group 3 - The independent directors and the accounting firm have confirmed that the use of raised funds to replace pre-invested self-raised funds and paid issuance costs complies with relevant regulations and does not harm shareholder interests [6][7] - The sponsor has verified that the necessary legal procedures were followed, and the replacement of funds occurred within six months of the funds being received [7][8]

Group 1 - The first meeting of the Supervisory Board of Jiangsu Hanbang Technology Co., Ltd. was held on June 17, 2025, with all three supervisors present [1] - The Supervisory Board approved the proposal to use raised funds to replace self-raised funds that were previously invested in projects and paid issuance expenses, totaling 56.548 million yuan [1] - The use of raised funds for this purpose will not affect the normal implementation of the fundraising projects and complies with relevant regulations [1][2] Group 2 - The voting result for the proposal was 3 votes in favor, 0 votes against, and 0 abstentions [2]